Lets Talk Finances

Provoking Discussion on Personal Finance and Investing

NARI - Inari Medical, Inc. ()

Overview

Company Summary


Inari Medical, Inc. (NARI) is a medical device company that focuses on developing and commercializing innovative treatments for patients with venous diseases. The company specializes in the field of interventional pulmonology and seeks to address unmet medical needs related to the treatment of venous thromboembolism (VTE) and other vascular conditions.

Inari Medical develops precise and minimally invasive catheter-based systems used by physicians to remove blood clots from the peripheral vasculature and preserve normal flow dynamics. Their flagship product, the FlowTriever System, is designed to be highly effective in the treatment of deep vein thrombosis (DVT), a condition characterized by the formation of blood clots in the deep veins of the body, often in the legs.

The FlowTriever System works by utilizing a proprietary mechanical thrombectomy technique to remove the clot from the blood vessel, restoring normal blood flow and reducing the risk of complications associated with DVT. This procedure is performed by interventional radiologists or vascular surgeons in a minimally invasive manner, allowing for shorter recovery times and improved patient outcomes compared to traditional surgical approaches.

In addition to their core product, Inari Medical also provides complementary therapies and devices, such as the ClotTriever System, which is specifically designed for the treatment of clots that occur in the pulmonary arteries (pulmonary embolism). These devices offer alternative treatment options for patients suffering from VTE and help address the varying needs of physicians in the field of interventional pulmonology.

Overall, Inari Medical aims to improve patient outcomes, enhance the quality of care, and reduce the economic burden associated with venous diseases through their innovative medical devices and therapies. They continuously invest in research and development to further advance their technologies, expand their product portfolio, and contribute to the advancement of medical science in the field of vascular health.

Notes (see all)

News